ViiV Healthcare, the global specialist HIV company majority owned by GSK, with Pfizer and Shionogi as shareholders, today announced positive findings from the company’s EMBRACE phase IIb study.
L and J-HZ by L&J Bio for Herpes Zoster (Shingles): Likelihood of Approval
L and J-HZ is under clinical development by L&J Bio and currently in Phase I for Herpes Zoster (Shingles).